All articles by Linda Stewart – Page 30
-
NewsChristian Gaebler receives ERC Starting Grant to study HIV patients living without medication
Prof. Christian Gaebler aims to develop treatments that cure HIV infection in patients or prompt the immune system to keep the virus in check in the long term, and has won funding to study patients who are already living without medication.
-
NewsRSV vaccination in older adults with health conditions is cost-effective
Targeting vaccination programs for respiratory syncytial virus (RSV) to older adults with underlying health conditions is a cost-effective way to reduce disease, according to a new modelling study.
-
NewsNatural probiotic discovered in UK newborns’ microbiomes
Newborn babies have one of three pioneer bacteria in their gut shortly after birth, one of which could be used to develop new personalised infant therapeutic probiotics, researchers show.
-
NewsHijacking the command center of the cell: nuclear parasites in deep-sea mussels
Researchers have revealed how a bacterial parasite thrives inside the nuclei of deep-sea mussels, a remarkable feat given that the nucleus is the control center of the cell.
-
NewsGame-changing purple bacteria can become bioplastic factories
Two new studies highlight one potential source of game-changing materials: purple bacteria that, with a little encouragement, can act like microscopic factories for bioplastics.
-
NewsSaline nasal drops reduce the duration of the common cold in young children by two days
Using hypertonic saline nasal drops can reduce the length of the common cold in children by two days, according to a study that will be presented at the European Respiratory Society (ERS) Congress.
-
NewsSkin fungus colonization accelerates breast cancer tumor growth
A common skin fungus, Malassezia globosa may invade deep tissues through the skin or by other means, then cause tumor growth, according to a new study.
-
NewsResearcher helps develop new technique to explore oceanic microbes
A new method makes it possible to collect microbial natural products where they are produced in the wild, without the need for lab culture. It uses an absorbent resin called HP-20, which acts like a sponge to capture the chemicals released by microbes.
-
NewsNew guideline for Helicobacter pylori includes change to primary treatment recommendation
New guidelines on the treatment of Helicobacter pylori (H. pylori) infection warn against prescribing PPI triple therapy, instead advising practitioners to use bismuth quadruple therapy or one of the other suggested treatment options.
-
NewsFungus uses surface protein of its spores to weaken human immune system
An international research team discovered a special enzyme on the surface of the spores of Aspergillus fumigatus apparently suppresses the release of pro-inflammatory substances by immune cells, making it easier for the pathogen to spread in the tissue.
-
NewsPublic health experts put out call for collaboration in antiviral therapeutics development coalition
Establishing a global therapeutics development coalition is a vital next step to invigorate the therapeutics pipeline and drive advocacy for increased investment and coordination of end-to-end therapeutics development, say a group of public health experts.
-
NewsStudy uncovers the specialized immune cells that fight COVID-19
A team of researchers from Osaka University has pinpointed the B cells responsible for boosting COVID-19 immunity after vaccination.
-
NewsResearchers discover key gene regulating virulence of fungus that causes severe lung infections
Scientists have found a potential target for novel therapeutic strategies to combat fungal infections caused by Aspergillus fumigatus and are now looking for a molecule that inactivates the protein expressed by the gene as a basis for a drug.
-
NewsImmune cells prevent lung healing after viral infection
Investigators have discovered a pathway by which immune cells prevent the lungs’ protective barrier from healing after viral infections like COVID-19.
-
NewsNew study provides insight to why Covid vaccines hit some harder than others
Scientists have highlighted factors that may explain why some people perceived more side effects from the SARS-CoV2 vaccine than others, including stress, exercise, and use of hormonal birth control.
-
NewsFirst narrow-spectrum antibiotic successfully eliminates Fusobacterium nucleatum in breakthrough study
Scientists found that FP 100 (Hygromycin A), a first-in-class, small molecule, narrow-spectrum antibiotic, successfully eradicates Fusobacterium nucleatum without harming the oral or gut microbiomes.
-
NewsInfections following hip replacement associated with an increased risk of death, study finds
Patients who develop a periprosthetic joint infection (PJI) after a total hip replacement have more than a five-fold increased risk of mortality within 10 years, according to new research.
-
NewsObesity may increase susceptibility to contracting COVID-19
Electronic health record data revealed that individuals with obesity were 34% more likely to become COVID positive after reported exposure than individuals without obesity.
-
NewsFirst phase of polio campaign concludes successfully in Gaza
More than 187,000 children under ten years of age were vaccinated with novel oral polio vaccine type 2 (nOPV2) in central Gaza during the first phase of a two-round polio vaccination campaign, conducted between 1–3 September 2024.
-
NewsMeet the Global Ambassadors: Our Q&A with Sergio L Alves jr
The Microbiologist chats with our new Global Ambassador for Brazil, Sergio L Alves jr, Associate Professor at the Federal University of Fronteira Sul (UFFS).
